LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 99 filers reported holding LYELL IMMUNOPHARMA INC in Q1 2023. The put-call ratio across all filers is 3.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $135,388 | -53.8% | 92,101 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $292,881 | +65.4% | 92,101 | +22.8% | 0.00% | +100.0% |
| Q1 2023 | $177,033 | -44.8% | 75,014 | -18.9% | 0.00% | -66.7% |
| Q4 2022 | $320,982 | -52.7% | 92,502 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $678,040 | +12.4% | 92,502 | 0.0% | 0.01% | +20.0% |
| Q2 2022 | $603,113 | +41.3% | 92,502 | +9.5% | 0.01% | +66.7% |
| Q1 2022 | $426,791 | +179.4% | 84,513 | +718.8% | 0.00% | +200.0% |
| Q3 2021 | $152,751 | – | 10,321 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $101,820,000 | 43.09% |
| Apoletto Ltd | 15,093,969 | $76,225,000 | 20.06% |
| Foresite Capital Management IV, LLC | 13,282,181 | $67,075,000 | 18.76% |
| HSG Holding Ltd | 3,045,997 | $15,382,000 | 1.92% |
| MIC Capital Management UK LLP | 1,320,000 | $6,666,000 | 1.30% |
| Alphabet Inc. | 5,865,125 | $29,619,000 | 0.96% |
| Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $8,322,000 | 0.47% |
| Adero Partners, LLC | 253,512 | $1,280,000 | 0.19% |
| Artal Group S.A. | 700,000 | $3,535,000 | 0.15% |
| Eagle Health Investments LP | 100,000 | $505,000 | 0.12% |